Tenon Medical, Inc.
TNON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $1 | $0 |
| % Growth | 11.9% | 323.7% | 331.9% | – |
| Cost of Goods Sold | $2 | $2 | $1 | $0 |
| Gross Profit | $2 | $1 | -$1 | $0 |
| % Margin | 52.2% | 42.4% | -92.8% | 65.6% |
| R&D Expenses | $3 | $3 | $3 | $2 |
| G&A Expenses | $8 | $7 | $7 | $3 |
| SG&A Expenses | $13 | $14 | $15 | $5 |
| Sales & Mktg Exp. | $5 | $7 | $8 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $15 | $17 | $18 | $7 |
| Operating Income | -$14 | -$16 | -$19 | -$6 |
| % Margin | -420.1% | -537.1% | -2,709.8% | -4,038.1% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$1 |
| Pre-Tax Income | -$14 | -$16 | -$19 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14 | -$16 | -$19 | -$7 |
| % Margin | -417.2% | -532.1% | -2,737.6% | -4,405% |
| EPS | -11.26 | -68.64 | -187.3 | -624.38 |
| % Growth | 83.6% | 63.4% | 70% | – |
| EPS Diluted | -11.26 | -68.64 | -187.3 | -624.38 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$13 | -$15 | -$18 | -$6 |
| % Margin | -396.2% | -516.9% | -2,644.6% | -3,966.3% |